“…During the past decade, however, the range of products has been expanded drastically and comprises nowadays not only other proteinogenic amino acids, such as L-valine ( Blombach et al, 2007a ; Schwentner et al, 2018 ), L-arginine ( Park et al, 2014 ), L-tryptophan ( Zhang et al, 2015 ), or L-histidine ( Schwentner et al, 2019 ), but also organic acids ( Wieschalka et al, 2013 ), alcohols ( Blombach et al, 2011 ), carotenoids ( Henke and Wendisch, 2019 ), and proteins ( Bakkes et al, 2020 ; Hemmerich et al, 2020 ). Moreover, C. glutamicum has been engineered to overproduce native compatible solutes such as trehalose ( Carpinelli et al, 2006 ) and L-proline ( Jensen and Wendisch, 2013 ), as well as the nonnative α-D-glucosylglycerol ( Roenneke et al, 2018 ), L-pipecolic acid ( Pérez-García et al, 2019 ), and ectoine/hydroxyectoine ( Gießelmann et al, 2019 ), principally demonstrating the capability of C. glutamicum to serve as a host for production of compatible solutes. Very recently, C. glutamicum has been also engineered to produce MG from glucose plus glycerate and from mannose plus glycerate in an artificially designed starch-mannose-fermentation biotransformation process, respectively ( Tian et al, 2020 ).…”